Emergent BioSolutions Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
EBS on NYSE
Industry
Pharmaceutical Preparations
Location
300 Professional Dr, Gaithersburg, MD

Insiders trading volume in the past year

Emergent BioSolutions Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard S. Lindahl EVP, Chief Financial Officer $2.8M Oct 15, 2025
Fuad El-Hibri Director $2.44M Dec 3, 2021
Joseph C. Papa President and CEO, Director $2M +$350K +21.2% May 13, 2025
Jennifer Lynne Fox EVP, Ext Aff, GC, Corp Sec $1.52M Jul 11, 2024
Coleen Glessner EVP, Quality & Ethics, and CPL $1.44M -$306K -17.5% Oct 7, 2025
Donald W. DeGolyer Director $1.26M -$255K -16.8% Nov 10, 2025
William Hartzel SVP, Bioservices $1.12M Nov 11, 2025
Robert Kramer President and CEO, Director $921K Jun 9, 2023
Sujata Tyagi Dayal Director $890K -$85.5K -8.77% Nov 7, 2025
Kathryn C. Zoon Director $637K -$120K -15.9% Aug 15, 2025
Louis W. Sullivan Director $611K Apr 30, 2025
Neal Franklin Fowler Director $595K -$204K -25.5% Apr 30, 2025
Paul Anthony Williams SVP, Products Business $569K Jun 8, 2025
Keith Katkin Director $545K -$49.4K -8.32% May 23, 2025
Zsolt Harsanyi Chairman, Director $543K Apr 30, 2025
Simon C. Lowry Svp, R&D, Cmo $533K Mar 6, 2025
Ronald Richard Director $463K Apr 30, 2025
Jessica Perl SVP, General Counsel, Corp Sec $397K Mar 6, 2025
Marvin L. White Director $388K Apr 30, 2025
Adam Havey EVP, Business Operations $317K Jun 9, 2023
Atul Saran EVP, Chief Strat & Dev Officer $158K Feb 28, 2023
Katherine Strei EVP, Chief HR Officer $114K Feb 28, 2023
Jerome M. Hauer Director $105K May 25, 2023
George A. Joulwan Director $73.2K May 26, 2022
Karen L. Smith EVP, Chief Medical Officer $21.6K May 7, 2021
H. Haywood Miller III Interim CEO Jun 24, 2023

Recent Insider Transactions by Companies or Individuals for Emergent BioSolutions Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.